SeaSpine to Participate in Upcoming Investor Conferences
SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its participation in two upcoming virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its participation in two upcoming virtual investor conferences. The first event is the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, featuring a fireside chat at 2:40 pm ET. The second is the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will have a pre-recorded fireside chat available on demand starting November 22, 2021. SeaSpine specializes in surgical solutions for spinal disorders, offering a diverse range of orthobiologics and spinal implants across the U.S. and approximately 30 countries.
Details
News Market Reaction – SPNE
The recorded move for SPNE in the trading session of this news was -1.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in upcoming virtual investor conferences.
Event: Stifel 2021 Virtual Healthcare Conference
Format: Fireside Chat
Date: Tuesday, November 16, 2021
Time: 2:40 pm ET
Event: Piper Sandler 33rd Annual Virtual Healthcare Conference
Format: Pre-recorded Fireside Chat
Date: Available on demand beginning Monday, November 22, 2021
About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions, as well as a market leading surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic, and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in orthobiologic sciences, as well as spinal implants, software, and advanced optics product development, allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.
Investor Relations Contact
Hunter Cabi
(904) 304-9505
ir@seaspine.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.